BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 17040873)

  • 1. [Functional characterization of naturally occurring CFTR mutants: interest for cystic fibrosis].
    Romey MC
    Ann Biol Clin (Paris); 2006; 64(5):429-37. PubMed ID: 17040873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cystic fibrosis: molecular update and clinical implications].
    Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
    Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cystic fibrosis: the CFTR gene, its mutations, the genetic counseling].
    Goossens M; Ghanem N; Girodon E; Costes B; Fanen P
    Rev Pneumol Clin; 1995; 51(3):130-6. PubMed ID: 7569574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant cystic fibrosis phenotypes in the absence of CFTR mutations.
    Groman JD; Meyer ME; Wilmott RW; Zeitlin PL; Cutting GR
    N Engl J Med; 2002 Aug; 347(6):401-7. PubMed ID: 12167682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
    Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
    Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
    Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
    Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular biological analysis of cystic fibrosis--a model example for the strategy of "reverse genetics"].
    Coutelle C; Grade K
    Padiatr Grenzgeb; 1992; 31(2):73-95. PubMed ID: 1284810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modifier genes and cystic fibrosis].
    Corvol H; Flamant C; Vallet C; Clement A; Brouard J
    Arch Pediatr; 2006 Jan; 13(1):57-63. PubMed ID: 16274977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
    Kerem E
    Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis: basic science.
    McAuley DF; Elborn JS
    Paediatr Respir Rev; 2000 Jun; 1(2):93-100. PubMed ID: 12531100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cystic fibrosis modifying genes].
    Knauer N; Ratjen F; Grasemann H
    Pneumologie; 2005 Jun; 59(6):395-404. PubMed ID: 15991075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CFTR protein and molecular mechanisms of pulmonary involvement in cystic fibrosis].
    Chinet T
    Rev Pneumol Clin; 1995; 51(3):122-9. PubMed ID: 7569573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misprocessing of the CFTR protein leads to mild cystic fibrosis phenotype.
    Clain J; Lehmann-Che J; Duguépéroux I; Arous N; Girodon E; Legendre M; Goossens M; Edelman A; de Braekeleer M; Teulon J; Fanen P
    Hum Mutat; 2005 Apr; 25(4):360-71. PubMed ID: 15776432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular diagnosis of cystic fibrosis.
    Kant JA; Mifflin TE; McGlennen R; Rice E; Naylor E; Cooper DL
    Clin Lab Med; 1995 Dec; 15(4):877-98. PubMed ID: 8838228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of the cystic fibrosis gene in the lungs].
    Heijerman HG; de Jonge HR
    Ned Tijdschr Geneeskd; 2004 Apr; 148(17):816-9. PubMed ID: 15141646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of the CFTR mutations 3272-26A-->G and L927P in Belgian cystic fibrosis patients, and identification of three new CFTR mutations (186-2A-->G, E588V, and 1671insTATCA).
    Storm K; Moens E; Vits L; De Vlieger H; Delaere G; D'Hollander M; Wuyts W; Biervliet M; Van Schil L; Desager K; Nöthen MM
    J Cyst Fibros; 2007 Nov; 6(6):371-5. PubMed ID: 17481968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
    BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation.
    Cormet-Boyaka E; Jablonsky M; Naren AP; Jackson PL; Muccio DD; Kirk KL
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8221-6. PubMed ID: 15141088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity of the basic defect of homozygous CFTR mutation genotypes in humans.
    Stanke F; Ballmann M; Bronsveld I; Dörk T; Gallati S; Laabs U; Derichs N; Ritzka M; Posselt HG; Harms HK; Griese M; Blau H; Mastella G; Bijman J; Veeze H; Tümmler B
    J Med Genet; 2008 Jan; 45(1):47-54. PubMed ID: 18178635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.